In Response: These letters focus on 3 potentially important factors for training effects in the SMARTEX trial (The SMARTEX Heart Failure Study): (1) adequate load increase, (2) control of exercise intensity, and (3) inherent patient characteristics. In addition, adherence to exercise seems crucial for long-term outcomes after a supervised program.
spectively, and there were no differences in body mass index or age between the interventions in either study.
A final lesson from SMARTEX comes from comparing follow-up data of HIIT and MCT versus the control group that just got a recommendation of regular exercise. After the 3-month supervised intervention period, all participants were encouraged to continue on their own by monthly phone calls. At retest 9 months later, there were no differences in primary or secondary outcomes, indicating that subsequent physical activity did not maintain initial improvements. This is a reminder of the need to integrate measures to enhance motivation and adherence in exercise interventions. 3 A major challenge in cardiac rehabilitation is helping those who need it most to implement and maintain lifestyle changes over time.
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